List of insiders holdings for ARENA PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Flynn James E DEERFIELD CAPITAL LP DEERFIELD MANAGEMENT CO DEERFIELD INTERNATIONAL LTD DEERFIELD PARTNERS LP 10% Owner |
2013-02-14 15:39:23 | 7,479,424 0 |
7,479,424 | Form 13G |
| 2 | LAMPERT MARK N Director 10% Owner |
2003-10-21 18:21:20 | 0 4,520,212 |
4,520,212 | Form 4 |
| 3 | LIEF JACK President and CEO |
2015-03-04 17:54:17 | 697,189 0 |
697,189 | Form 4 |
| 4 | BEHAN DOMINIC P EVP & Chief Scientific Officer |
2016-03-04 18:13:19 | 525,000 0 |
525,000 | Form 4 |
| 5 | CHALMERS DEREK T Former VP, Research and Dir. |
2004-06-14 21:45:13 | 370,667 0 |
370,667 | Form 4 |
| 6 | Bielasz Jennifer Kathleen VP, Finance and Accounting |
2016-03-04 18:20:10 | 252,000 0 |
252,000 | Form 4 |
| 7 | Audet Craig Michael SVP, Opn & Head Glob Reg Afrs |
2016-03-04 18:17:51 | 207,500 0 |
207,500 | Form 4 |
| 8 | SHANAHAN WILLIAM R JR SVP & Chief Medical Officer |
2016-03-04 18:16:01 | 207,500 0 |
207,500 | Form 4 |
| 9 | Mezzino Maurice James SVP, Corporate Development |
2016-03-04 18:18:55 | 175,000 0 |
175,000 | Form 4 |
| 10 | White Christine Anna Director |
2017-06-14 19:47:22 | 150,000 0 |
150,000 | Form 4 |
| 11 | SCHNEIDER PHILLIP M Director |
2017-06-14 19:46:25 | 150,000 0 |
150,000 | Form 4 |
| 12 | BICE SCOTT H Director |
2017-06-14 19:42:04 | 150,000 0 |
150,000 | Form 4 |
| 13 | AJIT-SIMH K A Sr. VP, Quality & Reg Compl |
2011-03-17 19:31:33 | 130,000 0 |
130,000 | Form 4 |
| 14 | BELCHER DONALD D Director |
2016-06-15 20:48:00 | 125,000 0 |
125,000 | Form 4 |
| 15 | HIXSON HARRY F JR Director |
2016-06-15 20:51:15 | 125,000 0 |
125,000 | Form 4 |
| 16 | Munshi Amit President and CEO |
2022-03-11 16:11:40 | 114,897 0 |
114,897 | Form 4 |
| 17 | HOFFMAN ROBERT SVP, Finance and CFO |
2014-12-17 19:47:13 | 103,074 0 |
103,074 | Form 4 |
| 18 | WILLIAMS JOYCE H Former VP, Drug Development |
2004-08-16 17:37:28 | 74,198 0 |
74,198 | Form 4 |
| 19 | BEELEY NIGEL R A Former VP, Chief Chem. Officer |
2004-06-09 19:49:35 | 70,907 0 |
70,907 | Form 4 |
| 20 | Klassen Preston EVP and CMO |
2020-03-03 18:15:19 | 70,000 0 |
70,000 | Form 4 |
| 21 | Lind Kevin Robert Executive VP and CFO |
2020-03-03 18:10:08 | 70,000 0 |
70,000 | Form 4 |
| 22 | Aurentz Vincent Executive VP and CBO |
2022-03-11 16:07:39 | 55,964 0 |
55,964 | Form 4 |
| 23 | Lisicki Robert EVP, Chief Commercial Officer |
2022-03-11 16:06:17 | 37,563 0 |
37,563 | Form 4 |
| 24 | Stelzer Laurie EVP & Chief Financial Officer |
2022-03-11 16:12:08 | 37,208 0 |
37,208 | Form 4 |
| 25 | Manion Douglas J. EVP Research & Development |
2022-03-11 16:12:30 | 36,462 0 |
36,462 | Form 4 |
| 26 | Schmidt Joan EVP, General Counsel & Sec |
2022-03-11 16:09:49 | 36,287 0 |
36,287 | Form 4 |
| 27 | LAFORCE JAMES Director |
2010-03-18 20:12:25 | 30,462 0 |
30,462 | Form 4 |
| 28 | MOONEY JOSEPH F Former Chief Financial Officer |
2004-01-05 20:23:49 | 27,785 0 |
27,785 | Form 4 |
| 29 | FRANK FREDERICK Advisory Director Director |
2004-01-21 19:09:15 | 25,000 0 |
25,000 | Form 4 |
| 30 | Nova Tina Susan Director |
2022-03-11 16:24:43 | 20,843 0 |
20,843 | Form 4 |
| 31 | SPECTOR STEVEN W EVP, General Counsel & Sec |
2020-02-28 18:02:34 | 17,437 0 |
17,437 | Form 4 |
| 32 | MAFFUID PAUL W VP, Pharmaceutical Development |
2004-07-02 18:56:26 | 16,604 0 |
16,604 | Form 4 |
| 33 | SCOTTI LOUIS J VP, Marketing and Business Dev |
2008-03-05 18:32:57 | 15,000 0 |
15,000 | Form 4 |
| 34 | WOODS RANDALL E Director |
2019-11-13 20:14:36 | 14,230 0 |
14,230 | Form 4 |
| 35 | GALLAHUE KIERAN Director |
2022-03-11 16:23:59 | 9,283 3,628 |
12,911 | Form 4 |
| 36 | Jarrett Jennifer Director |
2022-03-11 16:23:13 | 11,217 0 |
11,217 | Form 4 |
| 37 | NEIL GARRY ARTHUR Director |
2022-03-11 16:22:49 | 11,217 0 |
11,217 | Form 4 |
| 38 | LAVIGNE LOUIS J JR Director |
2006-08-01 19:51:23 | 10,000 0 |
10,000 | Form 4 |
| 39 | BRISTOW DUKE K Director |
2005-01-18 20:19:34 | 10,000 0 |
10,000 | Form 4 |
| 40 | TOMS ROBERT L Director |
2005-01-18 20:26:37 | 10,000 0 |
10,000 | Form 4 |
| 41 | FETZER OLIVER Director |
2022-03-11 16:24:23 | 9,692 0 |
9,692 | Form 4 |
| 42 | Dallas Jayson Donald Alexander Director |
2022-03-11 16:22:04 | 7,152 0 |
7,152 | Form 4 |
| 43 | Knobil Katharine Director |
2022-03-11 16:23:33 | 6,821 0 |
6,821 | Form 4 |
| 44 | Cabell Christopher EVP, Head of R&D, and CMO |
2020-11-30 16:01:24 | 6,401 0 |
6,401 | Form 4 |
| 45 | Soni Manmeet Singh Director |
2020-06-18 17:07:19 | 5,902 0 |
5,902 | Form 4 |
| 46 | Schoch Steven J Director |
2022-03-11 16:22:28 | 4,600 0 |
4,600 | Form 4 |
| 47 | Ouzren Nawal Director |
2022-03-11 16:21:42 | 4,555 0 |
4,555 | Form 4 |
| 48 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC Indirect Beneficial Owner 10% Owner |
2004-08-05 13:40:19 | 0 0 |
0 | Form 13D |